# Fennec Pharmaceuticals Inc.: Form 8-K, filed Jun 10, 2026

- Company: [Fennec Pharmaceuticals Inc.](/companies/fenc.md) (CIK 1211583)
- Form: 8-K
- Filed: 2026-06-10
- Accepted by EDGAR: Jun 10, 2026, 21:19 ET
- Period: 2026-06-10
- Accession: 0001104659-26-072425
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/tm2617550d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1211583/000110465926072425/tm2617550d1_8k.htm

Filed Jun 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-072425. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.